Ischemic heart disease is underdiagnosed in women due to atypical symptomatology as well as to the lower specificity of several paraclinical tests, such as exercise stress testing. The aim of the study was to ascertain whether the Duke treadmill score (DTS) could be an efficient parameter in the diagnosis of ischemic heart disease in women.
INTRODUCTION
Cardiovascular diseases are responsible for most deaths in women worldwide. Cardiovascular disease represents among Europe the leading cause of death in women. About 55% of deaths in women are due to these diseases, especially coronary heart disease and stroke [1] [2] [3] [4] [5] [6] [7] [8] .
According to AHA -Heart Disease and Stroke 2013 Statistical Update, published in the early 2013, the first three places in the world in terms of mortality from ischemic heart disease and stroke are occupied by the Russian Federation, Bulgaria and Romania [9] .
Although the last years have brought an upswing in the diagnosis and clinical management of women with different cardiovascular diseases, their risk of developing ischemic heart disease is still underestimated. This might be related with the perception that premenopausal women are protected by their hormones. The prevalence of cardiovascular pathology strongly climbs in post-menopausal women, catching up or even surpassing men. Unfortunately, ischemic heart disease is underdiagnosed and undertreated in women due to atypical symptomatology as well as to the lower specificity of several paraclinical tests, such as exercise stress testing [10] . The Duke treadmill score is a composite index which is used in the evaluation of symptomatic patients to predict the presence of coronary artery disease and their prognosis. So, investigating the relation between different cardiovascular (CV) conditions and the DTS may contribute to an early diagnosis and proper therapy of coronary artery disease (CAD) and also may advance the knowledge on this topic.
The goals of this study are to present the relationship of different cardiovascular conditions in women and DTS and the gender-related differences.
MATERIALS AND METHODS
We conducted an analytical transversal study of 105 cardiovascular consecutive patients admitted in the Cardiology Department of the Rehabilitation Hospital, Cluj-Napoca, Romania. Inclusion criteria were the presence of the chest pain. The selected patients were informed about the study protocol and gave their signed informed consent. The lot was compressed of 48 (45.71%) women and 57 (54.29%) men. All patients were assessed for the presence of cardiovascular risk factors: obesity, blood pressure, smoking status, lipid profile (total cholesterol, triglycerides, HDL-cholesterol, LDLcholesterol), fasting plasma glucose.
Overweight was defined as a body mass index (BMI) from 25 to 29 kg/(m) 2 and obesity as a BMI≥30 kg/(m) 2 [11] . Blood pressure was measured according to standard protocol as the mean of two readings after the participant was at rest for 5 min in a sitting position. According to current European Society of Cardiology guidelines, hypertension was classified as: mild hypertension (140/90 mmHg -159/99 mmHg), moderate hypertension (160/ 100 mmHg -179/109 mmHg) and severe hypertension (> 180/110 mmHg) [11] . Blood glucose was measured by the glucose oxidase method, and serum lipids, total cholesterol, triglycerides, high density cholesterol were measured using commercially available kits. Low density cholesterol was estimated using the Friedewald's formula. Using the criteria set out in the National Cholesterol Education Program Adult Treatment Panel III Approach to dyslipidemias total cholesterol levels over 200 mg/dL, LDL-cholesterol levels over 100 mg/dL, triglycerides plasma concentrations exceeding 150 mg/dL and HDL-cholesterol levels less than 46 mg/dL in women and 40 mg/dL in men were considered abnormal [12] .
All patients underwent maximal symptom limited exercise treadmill testing (ETT) using the standard Bruce protocol [13] . Heart rate, blood pressure and 12-lead ECGs were recorded before exercise, at the end of each exercise stage and after the first minute of the recovery phase. Exercise testing was discontinued for abnormal blood pressure or rhythm, ST segment depression ≥ 3 mm or limiting symptoms (angina, dyspnea or fatigue). An abnormal exercise ST response was defined as ≥ 1 mm of horizontal or down sloping ST depression or ≥1 mm of ST-segment elevation in leads without pathological Q waves.
Duke Treadmill Score (DTS) was calculated using the following formula: DTS=exercise time -(5 x ST deviation) -(4 x angina score index) [13] . The exercise time was measured in minutes with Bruce's protocol and the angina was scored with 0 -meaning no angina, 1-non-limiting angina with exercise and 2-exercise-limiting angina. DTS ranges from -25 to + 15. DTS divided the patients into three categories: low risk (DTS ≥ 5), moderate risk (DTS -11 to 5) and high risk (DTS ≤ -11), but because a DTS ≤ -11 was uncommon in those patients, the categories used were low risk (DTS ≥ 5) and moderate risk (DTS < 5).
Exercise capacity was measured in METs (metabolic equivalents of oxygen consumption = 1.4 watt/kg body weight). 1 MET is a unit of sitting/ resting oxygen uptake (≈3. Statistical analysis was performed using SPSS for Windows (v 16.0; IBM Corporation, Armonk, NY, USA) and MedCalc (v 10.3.0.0; MedCalc Software, Ostend, Belgium) software programs. The analysis of the differences between qualitative variables was performed using the χ2 test. The Kolmogorov-Smirnov test was used to assess the normal distribution of continuous numerical variables. The DTS was modeled as a continuous variable. A value of P< 0.05 was considered statistically significant.
RESULTS
The baseline demographic and clinical characteristics of the patients are summarized in Table 1 . Table 2 shows exercise treadmill testing (ETT) data. The mean ETT time as per Bruce protocol was 7.82 ± 2.68 minutes in women and 9.85 ± 3.18 minutes in men (p< 0.001). Exercise was stopped in 11 (22.92%) female patients and 4 (7.02%) male patients due to limiting angina. Maximum ST-segment deviation was 3mm during exercise in men and 2 mm in women. The mean ST deviation in women was 0.38 mm.
Although the percentages of men with truepositive and nondiagnostic tests were similar to women (89.48%-51 men vs. 89.58% -43 women), women were more likely to have moderate DTS risk (58.34% vs. 35.09%). Women with ST-segment depression ≥1 mm had a lower BMI (27.38 ± 2.44 vs. 31.99 ± 6.15; p=0.02) and a higher maximal heart rate (139.2 ± 17.19 vs. 123.34 ± 21.87, p=0.03) than those with a true-negative treadmill testing. We found no relation with ST-depression and age, systolic and diastolic blood pressure, plasma LDL-cholesterol or fasting plasma glucose - Table 3 . 36 (63.16%) ST segment depression induced during effort or in recovery of 1 mm or more. ** no ischaemic ST changes during the exercise test or immediately after effort, reaching or exceeding 85% of maximum predicted heart rate. *** a negative test, but without achieving 85% of maximum predicted heart rate. 41±5.03 vs 1.86±5.18, p=0.07) . Surprisingly, DTS was not significantly different in women previously diagnosed with valvular heart disease, chronic heart failure or ischemic heart disease in comparison to those without these diseases: 3.12± 5.4 vs 1.91±5.34 and 2.07±3.73 vs 2.07±3.73, respectively (p>0.05). But, there were differences in terms of DTS between hypertensive women compared to those without HTN (2.03±4.89 vs. 8.13 ±7.85; p=0.02). We found no relation between DTS and age either in women, or in men - Fig. 1 . 
DISCUSSION
Noninvasive diagnostic techniques, such as exercise treadmill testing or imaging methods, are indicated to symptomatic women with intermediate or high risk of cardiovascular disease [14] . Women suffering from angina pectoris are less likely than men to perform exercise treadmill tests or angiographies, despite the presence of CV symptoms and risk factors, which stratify them into high risk classes [15] . It is well known that exercise testing is less accurate in women, giving more false positive results [16] . However, only a quarter of women who have not performed an exercise test are referred to undergo other diagnostic investigations [16] .
Men with pectoral angina are more often referred for additional investigations, such as echocardiography, stress echocardiography or angiography and also coronary revascularization procedures, than women, even compared to those with an already diagnosed cardiac disease [14, 16] .
Exercise treadmill testing is the oldest diagnostic tool, but also the most widely used assessment of coronary artery disease. The pre-test probability of coronary artery disease is influenced by various parameters, including age and nature of the chest pain. Among women, a high pre-test probability of coronary artery disease may be estimated in those over 60 years with typical chest pain and also in those who present cardiovascular risk factors (diabetes, metabolic syndrome) [16] .
According to current guidelines, symptomatic, intermediate-risk women, able to maximal exercise with a normal baseline ECG, are referred for exercise testing [4, 16] .
Sensitivity and specificity of exercise testing are lower in women (61%, respectively 70%) than in men (72%, respectively 77%) [4, 14] . However, exercise stress testing shows a high negative 150 predictive value in women with a low pretest probability of CAD [14] .
ECG changes with exercise are less specific in women than in men (women are more likely than men to have baseline ST-segment changes and also low-voltage ECGs) [14] . ST-segment depression that occurs during exercise testing is less accurate in women than in men, so the results should be interpreted more carefully [15] . Although many clinicians usually rely only on ST segment changes, there are many other ETT variables that should be taken into account for major adverse cardiac events, prognosis, such as symptoms (unfortunately, without additional prognostic value in women), chronotropic and hemodynamic response, maximal exercise capacity, DTS, heart rate recovery (estimates longterm survival in women), maximal heart rate, ST / maximal heart rate ratio, QRS score [17] .
As mentioned above, Duke score is a highly effective diagnostic tool in predicting the likelihood of CAD among women. Patients with a high DTS risk are 376 times more likely to have angiographically significant coronary artery stenosis than those with a low DTS risk [18] . A study which enrolled 976 symptomatic women, who performed both exercise testing and coronary angiography, shows that DTS is more accurate in women than in men for excluding CHD. Also, they reported that CHD is significantly correlated with DTS risk categories -89.2% of high-risk DTS women had at least 1-vessel CHD with at least 75% stenosis [19] . In our study, more than half of women (58.34%) had moderate DTS risk. DTS also seems to be effective for predicting the risk of major adverse cardiac events, such as: cardiac death, myocardial infarction, revascularization procedures or survival in both sexes [20] . Thereby, a low-risk DTS is correlated with an annual mortality of approximately 25%, whereas in high-risk DTS patients these perecntages reach 25% [21] . The Women Take Heart Project, which included 5.636 asymptomatic women reported that those women with a moderate or high DTS risk had hazard ratios for death that were 2 times higher than those with a low-risk DTS [22] . Also, the same study showed that for each unit of DTS increase, there was a 9% reduction in mortality rate [22] .
Previous studies assessed the diagnostic and prognostic value of the DTS, but few studies investigated the gender-related differences regarding the correlation between cardiovascular risk factors and reduced DTS. The results of the current report reveal that lower Duke scores were more likely to be recorded in women with cardiac diseases, such as chronic heart failure, valvular heart disease, or history of ischemic heart disease in comparison with men. Also, DTS was significantly lower in women with cardiac risk factors, including hypertension, diabetes mellitus, high plasma lipid fractions values, obesity, than in men.
A recent study published in Nigeria reported no differences in DTS between men and women diagnosed with diabetes mellitus [23] . There are studies demonstrating that DTS is also an important predictor of MACE in diabetic patients [24] . We found no data in the specialized literature regarding the possible correlations between DTS, other CV risk factors, besides diabetes mellitus and the risk of developing further cardiovascular events.
Nonetheless, among women lower scores were found only in hypertensive women in comparison with those without HTN. Although, these gender-differences regarding DTS are useful for understanding care delivery, it is important to determine whether the differences found demand a gender-based treatment disparity.
We found no relation between DTS and age in women. However, other studies propose that age should be added to the original DTS for a better diagnostic and prognostic value in women [25] .
Several limitations of this study should be noted. First, our study included a relatively small number of patients. Also, due to the design of the study selection bias may have occurred.
Our study enrolled both women and men in an adequate number to record statistically significant results. The major advantage of the current study is the possibility of investigating the differences between the two sexes, in addition to a proper analysis of the data generated by women. Taking into account the recommendations posted by the European Society of Cardiology, we performed an analysis regarding the presence of cardiovascular risk factors and CV diseases for each of the two sexes in part, investigating the relation between them and the DTS. By this, we tried to bring more information in this area of knowledge not fully elucidated yet.
CONCLUSION
Overall, among this cohort of patients we identified lower DTS in women with cardiovascular risk factors and cardiac disease than in men. We believe that our research, which showed significant differences in DTS between women and men, raises concerns about the early diagnosis of ischemic heart disease in women. However, it remains unclear whether these differences are justified. 
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